EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC 4.0

Health‐related quality of life in patients with primary sclerosing cholangitis: A longitudinal population‐based cohort study

Bregje Mol iD, Kim N van Munster iD, Johannes A Bogaards, Rinse K Weersma, Akin Inderson, E Joline de Groof, Noortje G M Rossen, Willemijn Ponsioen, Maud Turkenburg, Karel J van Erpecum, Alexander C Poen, B W Marcel Spanier und 3 weitere

Liver International · 2023-05 · 43 (5) · 1056-1067

DOI: 10.1111/liv.15542 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Liver International, online erschienen am 28.02.2023. Verfasst von Bregje Mol und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Amsterdam University Medical Centre, Location AMC, Amsterdam Gastroenterology, Endocrinology & Metabol…. Hauptthemen laut MEDLINE: Cholangitis, Sclerosing, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: ZonMw.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background & Aims Data regarding health‐related quality of life (HRQoL) in primary sclerosing cholangitis (PSC) are sparse and have only been studied cross‐sectionally in a disease which runs a fluctuating and unpredictable course. We aim to describe HRQoL longitudinally by using repeated measurements in a population‐based cohort.

Methods

Every 3 months from May 2017 up to August 2020, patients received digital questionnaires at home. These included the EQ‐5D, 5‐D Itch, patient‐based SCCAI and patient‐based HBI. The SF‐36, measuring HRQoL over eight dimensions as well as a physical component summary (PCS) and mental component summary (MCS) score, was sent annually. Data were compared with Dutch reference data and a matched IBD disease control from the population‐based POBASIC cohort. Mixed‐effects modelling was performed to identify factors associated with HRQoL.

Results

Three hundred twenty‐eight patients completed 2576 questionnaires. A significant reduction of small clinical relevance in several mean HRQoL scores was found compared with the Dutch reference population: 46.4 versus 48.0, p = .018 for PCS and 47.5 versus 50.5, p = .004 for MCS scores. HRQoL outcomes were significantly negatively associated with coexisting active IBD (PCS −12.2, p < .001 and MCS −12.0, p < .001), which was not the case in case of quiescent IBD. Decreasing HRQoL scores were also negatively associated with increasing age (PCS −0.1 per 10 years, p = .002), female sex (PCS ‐2.8, p < .001), diagnosis of AIH overlap (PCS ‐3.7, p = .059), end‐stage liver disease (PCS ‐3.7, p = .015) and presence of itch (PCS ‐9.2, p < .001 and MCS −3.1, p = .078). The odds of reporting a clinically relevant reduction in EQ‐5D scores showed seasonal variation, being lowest in summer (OR = 0.48 relative to spring, p = .037). In patients with liver transplant, HRQoL outcomes were comparable to the Dutch general population.

Conclusions

PSC patients report impaired HRQoL of small clinical relevance compared with the general population. After liver transplantation, HRQoL scores are at comparable levels to the general population. HRQoL scores are associated with potentially modifiable factors such as itch and IBD activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cholangitis, SclerosingInflammatory Bowel DiseasesHumansFemaleChildQuality of LifeCohort StudiesSurveys and Questionnaires

Stichwörter der Autor:innen

health-related quality of lifeinflammatory bowel diseasepopulation-based cohortpost-transplantprimary sclerosing cholangitisrepeated measurements

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, Amsterdam University Medical Centre, Location AMC, Amsterdam Gastroenterology, Endocrinology & Metabolism, Amsterdam, the Netherlands.
  • Department of Epidemiology and Data Science, Amsterdam University Medical Centre, location AMC, Amsterdam, the Netherlands.
  • Department of Gastroenterology and Hepatology, University Medical Centre Groningen, Groningen, the Netherlands.
  • Department of Gastroenterology and Hepatology, Leiden University Medical Centre, Leiden, the Netherlands.
  • Department of Gastroenterology and Hepatology, University Medical Centre Utrecht, Utrecht, the Netherlands.
  • Department of Gastroenterology and Hepatology, Isala Hospital, Zwolle, the Netherlands.

ORCID-Profile: Bregje Mol, Kim N van Munster, Ulrich H W Beuers, Cyriel Y Ponsioen

Förderung

  • ZonMw

Zitieren

APA

Mol, B., van Munster, K. N., Bogaards, J. A., Weersma, R. K., Inderson, A., de Groof, E. J., Rossen, N. G. M., Ponsioen, W., Turkenburg, M., van Erpecum, K. J., Poen, A. C., Spanier, B. W. M., Beuers, U. H. W., Ponsioen, C. Y., & EpiPSC2 study group (2023). Health‐related quality of life in patients with primary sclerosing cholangitis: A longitudinal population‐based cohort study. Liver International, 43(5), 1056-1067. https://doi.org/10.1111/liv.15542

Vancouver

Mol B, van Munster KN, Bogaards JA, Weersma RK, Inderson A, de Groof EJ, et al. Health‐related quality of life in patients with primary sclerosing cholangitis: A longitudinal population‐based cohort study. Liver International. 2023;43(5):1056-1067. doi:10.1111/liv.15542

BibTeX
@article{Mol2023,
  author = {Mol, Bregje and van Munster, Kim N and Bogaards, Johannes A and Weersma, Rinse K and Inderson, Akin and de Groof, E Joline and Rossen, Noortje G M and Ponsioen, Willemijn and Turkenburg, Maud and van Erpecum, Karel J and Poen, Alexander C and Spanier, B W Marcel and Beuers, Ulrich H W and Ponsioen, Cyriel Y and EpiPSC2 study group, EpiPSC2 study group},
  title = {Health‐related quality of life in patients with primary sclerosing cholangitis: A longitudinal population‐based cohort study},
  journal = {Liver International},
  year = {2023},
  volume = {43},
  number = {5},
  pages = {1056--1067},
  doi = {10.1111/liv.15542}
}
Kostenlos starten →